Under construction – not a live service
Sign in
Taking people in BelgiumNo phase

Checking home breathing support in people with Duchenne muscular dystrophy

Tests whether home sleep studies can guide breathing support in adults with Duchenne.

Plain-language title generated from the registry record
Registry title: Follow-up of NIV At Home in Patients with Duchenne Muscular Dystrophy

Key facts

Where
Leuven, BelgiumSee the site

Where in Belgium

  • Universitaire Ziekenhuizen KU LeuvenLeuven, BelgiumTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Universitaire Ziekenhuizen KU Leuven
Trial code
NCT06773988
Record updated
14 January 2025
Original description
The aim of this study is to verify whether full video home polysomnography (sleep study) with nocturnal transcutaneous CO2 monitoring is feasible in the follow-up of non-invasive ventilation (NIV) in patients with Duchenne muscular dystrophy. The researchers would like to investigate whether they could perform sufficient measurements in the home situation and see if correct decision for further treatment could be made. Furthermore, the researchers will make an analysis on the minimal requirements of measurements to make a correct decision for the treatment of these patients.Read full original descriptionShow less

Follow-up of NIV At Home in Patients with Duchenne Muscular Dystrophy

The aim of this study is to verify whether full video home polysomnography (sleep study) with nocturnal transcutaneous CO2 monitoring is feasible in the follow-up of non-invasive ventilation (NIV) in patients with Duchenne muscular dystrophy. The researchers would like to investigate whether they could perform sufficient measurements in the home situation and see if correct decision for further treatment could be made. Furthermore, the researchers will make an analysis on the minimal requirements of measurements to make a correct decision for the treatment of these patients.

Inclusion: Patients with DMD > 18 years using NIV; Signing the written informed consent.

Exclusion: /.

ClinicalTrials.gov NCT06773988